RP Cure Tracker

Trials / NCT07228793

Natural History Study of Patients With EYS-Associated RP

Recruiting now Observational Natural history / observational

Sponsor
Sensor Technology for Deafblind
Treatment
Whole exome/genome sequencing
Gene
EYS
Conditions
Retinitis Pigmentosa, Eye Diseases
Ages
14 Years to 100 Years
Enrollment
45 participants
Started
2025-11-07
Main results expected
2029-12-15
Results posted
Not yet
Record last updated
2026-04-28

What the study is testing

This natural history study of patients with EYS mutations from Russia and former CIS (Commonwealth of Independent States) territories will accelerate the development of outcome measures for clinical trials. Sensitive, reliable outcome measures of retinal degeneration will greatly facilitate development of treatments for retinitis pigmentosa due to EYS mutations. This approach helps to develop experimental treatment protocol, and assessing its effectiveness.

The goals and expected impact of this natural history study are to:

  1. Describe the natural history of retinal degeneration in patients with biallelic mutations in EYS gene in Russia and former CIS territories.
  2. Identify sensitive structural and functional outcome measures to use for future multicenter clinical trials in EYS-related retinal degeneration in Russia and former CIS territories.
  3. Identify well-defined subpopulations for future clinical trials of investigative treatments for EYS-related retinal degeneration in Russia and former CIS territories.

Where it runs

Russia (1)

Open on ClinicalTrials.gov for contacts and eligibility